UHN: Takeda licenses small molecule developed by researchers at UHN’s Krembil Brain Institute, targeting tau protein implicated in Alzheimer’s disease
(Toronto, April 11, 2023) – As announced today in a press release by biotechnology company Treventis, global pharmaceutical company Takeda...
Read More